60SCIENCE
⚡ Markets: Positive long-term signal for the biotech sector, particularly companies utilizing AI for drug discovery and those focused on longevity. May boost sentiment for specific AI and biotech stocks.
An early clinical study suggests a new drug for pulmonary fibrosis, designed using artificial intelligence, may reverse biological aging by 3-4 years. The drug, developed by Insilico Medicine, was found to reduce markers across multiple types of 'aging clocks'.
West MSM: noneGoogle Non-West 22 countries
2 sources across the spectrum